Gibson Christopher 4
4 · RECURSION PHARMACEUTICALS, INC. · Filed Apr 24, 2026
Research Summary
AI-generated summary of this filing
Recursion (RXRX) Director Christopher Gibson Sells 40,000 Shares
What Happened
Christopher Gibson, a director of Recursion Pharmaceuticals (RXRX), converted 40,000 convertible Class B shares into Class A common stock and sold 40,000 Class A shares in an open-market transaction on April 22, 2026. The shares sold were transacted at $3.61 per share for total proceeds of $144,400. The conversion was recorded at $0.00 per share (no cash payment for conversion).
Key Details
- Transaction date: April 22, 2026. Sale price: $3.61 / share; total proceeds $144,400.
- Conversion: 40,000 Class B shares converted to Class A (recorded at $0.00).
- Sale type: Open market sale reported under Form 4. The sale was executed pursuant to a Rule 10b5-1 trading plan adopted May 12, 2025 (footnote F2).
- Shares owned after transaction: Not specified in the provided filing data.
- Relevant footnotes: F1 (Class B shares are convertible into Class A at holder's option, no expiration) and F2 (10b5-1 plan). Other vesting/holding footnotes in the filing relate to separate option and entity holdings.
Context
This was a conversion of convertible shares followed by an immediate open-market sale — not an option exercise-for-stock-and-hold. The use of a pre-established 10b5-1 plan indicates the sale was prearranged; such planned sales are commonly used to avoid appearance of trading on material nonpublic information. The filing appears timely (filed April 24, 2026, for the April 22 transaction).
Insider Transaction Report
- Conversion
Class A Common Stock
[F1][F2]2026-04-22+40,000→ 946,556 total - Sale
Class A Common Stock
[F2]2026-04-22$3.61/sh−40,000$144,400→ 906,556 total - Conversion
Class B Common Stock
[F1][F2]2026-04-22−40,000→ 4,403,334 totalExercise: $0.00→ Class A Common Stock (40,000 underlying)
- 386,000(indirect: By LLC)
Class B Common Stock
[F1][F3]Exercise: $0.00→ Class A Common Stock (0 underlying) - 388,000(indirect: By LLC)
Class B Common Stock
[F1][F4]Exercise: $0.00→ Class A Common Stock (0 underlying) - 50,000(indirect: By Trust)
Class B Common Stock
[F1][F5]Exercise: $0.00→ Class A Common Stock (0 underlying) - 1,050,567
Stock Option (Right to Buy)
[F6]Exercise: $7.25Exp: 2035-02-03→ Class A Common Stock (0 underlying) - 666,898
Stock Option (Right to Buy)
[F7]Exercise: $10.09Exp: 2034-02-09→ Class A Common Stock (0 underlying) - 813,600
Stock Option (Right to Buy)
[F8]Exercise: $8.55Exp: 2033-02-01→ Class A Common Stock (0 underlying) - 399,002
Stock Option (Right to Buy)
[F9]Exercise: $11.40Exp: 2032-02-04→ Class A Common Stock (0 underlying) - 5,436
Stock Option (Right to Buy)
Exercise: $11.40From: 2022-02-04Exp: 2032-02-04→ Class A Common Stock (0 underlying) - 282,500
Stock Option (Right to Buy)
[F10]Exercise: $2.48Exp: 2030-12-30→ Class A Common Stock (0 underlying)
Footnotes (10)
- [F1]Each share of Class B Common Stock is convertible into one share of Class A Common Stock at the option of the holder and has no expiration date.
- [F10]The option, originally for 1,500,000 shares, vested as to one forty-eighth (1/48th) of the shares subject to the option on January 31, 2021, and one forty-eighth (1/48th) of the shares subject to the option shall vest each month thereafter.
- [F2]This transaction is pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on May 12, 2025.
- [F3]The shares are held by LAHWRAN-3 LLC, of which the Reporting Person is a member and a manager.
- [F4]The shares are held by LAHWRAN-4 LLC, of which the Reporting Person is a member and a manager.
- [F5]The shares are held by the Gibson Family Trust, of which the Reporting Person serves as Trustee.
- [F6]The option vests as to one forty-eighth (1/48th) of the shares subject to the option on March 1, 2025, and one forty-eighth (1/48th) of the shares subject to the option will vest each month thereafter.
- [F7]The option vests as to one forty-eighth (1/48th) of the original 666,898 shares subject to the option on March 1, 2024, and one forty-eighth (1/48th) of the shares subject to the option will vest each month thereafter.
- [F8]The option vests as to one forty-eighth (1/48th) of the shares subject to the option on March 1, 2023, and one forty-eighth (1/48th) of the shares subject to the option will vest each month thereafter.
- [F9]The option, originally for 416,350 shares, vested as to one forty-eighth (1/48th) of the shares subject to the option on March 1, 2022, and one forty-eighth (1/48th) of the shares subject to the option will vest each month thereafter.